Overall Survival Improved for Contemporary Patients with Melanoma: A 2004–2015 National Cancer Database Analysis

by Norma E. Farrow, Megan C. Turner, April K. S. Salama, Georgia M. Beasley
Published 2020-05-01

Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer

by Eda K. Holl, Victoria N. Frazier, Karenia Landa, Georgia M. Beasley, E. Shelley Hwang, Smita K. Nair
Published 2019-07-01

Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy

by Nicholas C. DeVito, Michael Sturdivant, Balamayooran Thievanthiran, Christine Xiao, Michael P. Plebanek, April K.S. Salama, Georgia M. Beasley, Alisha Holtzhausen, Veronica Novotny-Diermayr, John H. Strickler, Brent A. Hanks
Published 2021-05-01

Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma

by Matthias Gromeier, Darell D Bigner, Smita K Nair, Karenia Landa, Sin-Ho Jung, Georgia M Beasley, Norma E Farrow, Maria Angelica Selim, Carol Ann Wiggs, Andrea True Kelly, April KS Salama
Published 2021-04-01

Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling

by Michael C. Brown, Mubeen M. Mosaheb, Malte Mohme, Zachary P. McKay, Eda K. Holl, Jonathan P. Kastan, Yuanfan Yang, Georgia M. Beasley, E. Shelley Hwang, David M. Ashley, Darell D. Bigner, Smita K. Nair, Matthias Gromeier
Published 2021-03-01